Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119059052 | 11905905 | 2 | F | 201004 | 20150819 | 20160111 | 20160822 | PER | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2015US-101495 | RANBAXY | 65.97 | YR | F | Y | 48.00000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119059052 | 11905905 | 1 | SS | Atorvastatin | ATORVASTATIN | 1 | Oral | 20 MG, QD | Y | 0 | 20 | MG | |||||||
| 119059052 | 11905905 | 2 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | Y | 77974 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119059052 | 11905905 | 1 | Blood cholesterol increased |
| 119059052 | 11905905 | 2 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119059052 | 11905905 | Dizziness | |
| 119059052 | 11905905 | Feeling abnormal | |
| 119059052 | 11905905 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119059052 | 11905905 | 1 | 201004 | 201407 | 0 | |
| 119059052 | 11905905 | 2 | 201004 | 201407 | 0 |